Asensus Surgical (ASXC)
(Delayed Data from AMEX)
$0.34 USD
0.00 (0.00%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $0.34 0.00 (0.15%) 4:32 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Asensus Surgical, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 21 | 71 | 98 | 16 | 10 |
Receivables | 4 | 2 | 1 | 1 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 7 | 8 | 9 | 10 | 11 |
Other Current Assets | 5 | 6 | 6 | 7 | 7 |
Total Current Assets | 36 | 87 | 113 | 34 | 28 |
Net Property & Equipment | 9 | 10 | 11 | 10 | 5 |
Investments & Advances | 0 | 4 | 37 | 0 | 0 |
Other Non-Current Assets | 4 | 5 | 7 | 9 | 8 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1 | 2 | 10 | 22 | 31 |
Deposits & Other Assets | 3 | 4 | 2 | 3 | 3 |
Total Assets | 59 | 116 | 186 | 78 | 75 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 1 | 0 |
Accounts Payable | 4 | 3 | 3 | 2 | 4 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 7 | 6 | 5 | 6 | 9 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 1 | 1 | 1 |
Total Current Liabilities | 13 | 10 | 10 | 10 | 13 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 2 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 8 | 1 | 2 | 5 | 5 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 26 | 16 | 17 | 17 | 19 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 973 | 963 | 955 | 781 | 720 |
Retained Earnings | -939 | -861 | -785 | -723 | -664 |
Other Equity | -1 | -2 | 0 | 3 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 33 | 100 | 169 | 62 | 56 |
Total Liabilities & Shareholder's Equity | 59 | 116 | 186 | 78 | 75 |
Total Common Equity | 33 | 100 | 169 | 62 | 56 |
Shares Outstanding | 264.30 | 236.80 | 234.30 | 116.20 | 20.60 |
Book Value Per Share | 0.13 | 0.42 | 0.72 | 0.53 | 2.70 |
Fiscal Year End for Asensus Surgical, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 8 | 21 | 33 | 40 |
Receivables | NA | 1 | 4 | 1 | 1 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 6 | 7 | 7 | 9 |
Other Current Assets | NA | 5 | 5 | 6 | 5 |
Total Current Assets | NA | 19 | 36 | 46 | 55 |
Net Property & Equipment | NA | 9 | 9 | 9 | 9 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 4 | 4 | 6 | 5 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1 | 1 | 1 | 1 |
Deposits & Other Assets | NA | 3 | 3 | 3 | 3 |
Total Assets | NA | 41 | 59 | 71 | 78 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 4 | 4 | 5 | 4 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 5 | 7 | 6 | 5 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 9 | 0 | 0 | 0 |
Total Current Liabilities | NA | 19 | 13 | 12 | 11 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 8 | 7 | 2 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 28 | 26 | 23 | 17 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 976 | 973 | 971 | 966 |
Retained Earnings | NA | -962 | -939 | -922 | -904 |
Other Equity | NA | -1 | -1 | -2 | -1 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 13 | 33 | 47 | 62 |
Total Liabilities & Shareholder's Equity | NA | 41 | 59 | 71 | 78 |
Total Common Equity | 0 | 13 | 33 | 47 | 62 |
Shares Outstanding | 272.30 | 272.30 | 264.30 | 263.80 | 239.40 |
Book Value Per Share | 0.00 | 0.05 | 0.13 | 0.18 | 0.26 |